Johnson & Johnson
JNJ
#21
Rank
C$672.11 B
Marketcap
C$278.97
Share price
-0.27%
Change (1 day)
36.27%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): C$14.74

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is C$14.42. In 2024 the company made an earnings per share (EPS) of C$9.24 a decrease over its 2023 EPS that were of C$19.92.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.7459.41%
2024C$9.24-53.6%
2023C$19.92111.16%
2022C$9.43-13.84%
2021C$10.9541.81%
2020C$7.72-18.92%
2019C$9.5221.2%
2018C$7.861125.3%
2017C$0.64-92.23%
2016C$8.257.37%
2015C$7.68-4.16%
2014C$8.0218.1%
2013C$6.7924.88%
2012C$5.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$2.38-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.49-27.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.17-29.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$5.12-64.50%๐Ÿ‡ซ๐Ÿ‡ท France
Stryker Corporation
SYK
C$10.65-26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$5.01-65.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$28.35 96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.13-22.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$4.97-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
C$9.01-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA